Artificial Intelligence and Biostatistics: Revolutionizing Medical Research

Zelina Pose^*
*Correspondence: Zelina Pose, Department of Biostatistics, University of Dhaka, Dhaka, Bangladesh, Email:

Keywords

Biostatistics • Artificial intelligence • Data science

Introduction

AI-powered systems can assist healthcare professionals in making clinical decisions. For example, machine learning models can help predict patient outcomes, recommend treatment options, and identify potential drug interactions based on patient data and medical literature. Biostatistics plays a role in designing and validating these AI models. In pharmaceutical research, AI can expedite drug discovery processes by analyzing vast molecular datasets, predicting potential drug candidates, and simulating drug interactions. Biostatisticians can work alongside AI scientists to design experiments, assess the statistical significance of findings, and ensure that the results are robust and reproducible. AI is widely used in genomics and proteomics research for tasks like DNA sequence analysis, protein structure prediction, and identification of genetic markers associated with diseases. Biostatistics is essential for designing experiments, conducting genetic association studies, and assessing the statistical significance of genetic findings [1-3].

Literature Review

Biostatisticians play a pivotal role in designing clinical trials, determining sample sizes, and analyzing trial data to assess the safety and efficacy of new drugs and medical interventions. AI can assist in patient recruitment, monitoring trial progress, and identifying potential adverse events or treatment responses. AI and biostatistics are crucial in the development of personalized medicine approaches. By analyzing patient data, including genetics, medical history, and lifestyle factors, AI can help tailor treatments and interventions to individual patients. Biostatistics ensures the statistical validity of these personalized medicine approaches. AI models can be trained to predict disease outbreaks, assess population health trends, and recommend preventive measures. Biostatistics can provide the statistical framework for validating these predictions and assessing their accuracy. As AI is integrated into healthcare and biostatistics, there are ethical and regulatory challenges to address. Ensuring data privacy, transparency in AI algorithms, and adherence to regulatory standards are areas where both fields intersect [4,5].

AI is integrated into healthcare and biostatistics

AI-powered diagnostic tools can analyze medical images (e.g., X-rays, MRIs, CT scans) and pathology slides to detect diseases like cancer, fractures, or neurological disorders. Machine learning algorithms can assess patient data to identify individuals at higher risk for certain diseases, enabling early intervention and preventive measures. To obtain accurate aortoventricular angle measurements, it is necessary to maximize the angle between the annular plane and the horizontal plane in a lateral view, which may not be in the coronal plane. AI is used in drug discovery to analyze vast datasets related to chemical compounds, predict potential drug candidates, and assess their safety and efficacy. Machine learning models can accelerate the identification of drug targets and biomarkers for specific diseases. AI analyzes patient data, including genetics, medical history, and treatment responses, to tailor treatment plans for individual patients, optimizing therapeutic outcomes [6].

Discussion

The Authority for Working Conditions (ACT) has a publication with practical guidelines as an example that clarifies and specifies a set of situations that may be considered as a reference for the ACT's action, based on the United Kingdom law “Reporting of Injuries, Diseases, and Dangerous Occurrences Regulations” because the legislation in Portugal does not have a typification for serious accidents. These examinations, extremely pertinent to all doctors and patients engaged with TAVR, likewise underline a normal test to the rehearsing local area of how to manage apparently grating information unavoidable in different kinds of imaging concentrates too. For instance, early reports of indicative execution of virtually all imaging techniques for coronary corridor illness assessment revealed especially high precision that decremented after some time.

Conclusion

The text suggests that the 3-layered contraction of the ventricle during systole, which includes twist, may also affect aortoventricular angle measurements. This implies that the angle may vary depending on the time within the cardiac cycle at which it is measured. Therefore, accurate measurement of the aortoventricular angle may require consideration of these factors and standardization of measurement protocols. When a worker or self-employed worker who works in other people's facilities suffers a serious physical injury that necessitates specialized medical treatment, it is established that an occupational accident indicates a particularly serious situation. How could clinicians (and diary editors) digest these dissonant messages? Would it be advisable for one be worried about the wellbeing of oneself extending prosthesis in view of the significant information of the other hand be consoled by the complex bigger dataset. Instead of rushing to make a judgment call that this finding is unvaryingly valid or false, the actual examinations ought to be inspected for significant subtleties that might have delivered dissonant outcomes from comparative picture logical approaches.

Acknowledgement

We thank the anonymous reviewers for their constructive criticisms of the manuscript. The support from ROMA (Research Optimization and recovery in the Manufacturing industry), of the Research Council of Norway is highly appreciated by the authors.

Conflict of Interest

The authors declare that there was no conflict of interest in the present study.

References

1. Waller, Lance A. "Biostatistics and artificial intelligence." Cham: Springer International Publishing (2022): 95-101.

Google Scholar, Crossref, Indexed at

2. Lopes, Bernardo, Isaac Carvalho de Oliveira Ramos, Guilherme Ribeiro and Rosane Correa, et al. "Biostatistics: Fundamental concepts and practical applications." Rev Bras Oftalmol 73 (2014): 16-22.

Google Scholar, Crossref, Indexed at

3. Goldstein, Neal D., Michael T. LeVasseur and Leslie A. McClure. "On the convergence of epidemiology, biostatistics, and data science." Harv Data Sci Rev 2 (2020): 2020.

Google Scholar, Crossref, Indexed at

4. Garg, A. P. and N. Bisht. "Role of biostatistics and biometrics based artificial intelligence in human medicare system in 2050." Biom Biostat Int J 12 (2023): 27-32.

Google Scholar, Crossref, Indexed at

5. Cui, Elvis Han, Zizhao Zhang, Culsome Junwen Chen and Weng Kee Wong. "Metaheuristic Algorithms in Artificial Intelligence with Applications to Bioinformatics, Biostatistics, Ecology and, the Manufacturing Industries." arXiv preprint arXiv 2308.10875 (2023).

Google Scholar, Indexed at

6. Chiappelli, Francesco, Nicole Balenton and Allen Khakshooy. "Future innovations in viral immune surveillance: A novel place for bioinformation and artificial intelligence in the administration of health care." Bioinformation 14 (2018): 201.

Google Scholar, Crossref, Indexed at